Solid-state characterization and dissolution properties of ezetimibe-cyclodextrins inclusion complexes

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 60, Issue 3-4, 2008, Pages 241-251

  Patel, R ^a   Bhimani, D ^a   Patel, J ^a   Patel, D ^a  

^a GANPAT UNIVERSITY   (India)

Author keywords

Cyclodextrin; Characterization; DSC; Ezetimibe; FTIR; Hydroxypropyl cyclodextrin; In vitro dissolution studies; Mean dissolution time; PXRD; Similarity factor

Indexed keywords

EID: 41549152442     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-007-9371-7     Document Type: Article

References (19)

1. Proudfoot, S.: Factors affecting bioavailability: factors influencing drug absorption from the gastrointestinal tract. In: Aulton, M.E. (Ed.), Pharmaceutics: The Science of Dosage From Design, pp. 135-173. Churchill Livingstone London, UK (1991)
2. Pitha, J., Milecki. J., Fales, H., Pannell, L., Uekama, K.: Hydroxypropyl-β-cyclodextrin: preparation and characterization; Effects on solubility of drugs. Int. J. Pharm. 29: 73-82 (1986)
3. Duchêne, D.: Cyclodextrins and their industrial uses. Editions de Santé Paris, SS. 447-460 (1987)
4. Uekama, K., Otagiri, M.: Cyclodextrins in drug carrier systems. Crit. Rev. Ther. Drug Carrier Syst. 3, 1-40 (1987)
5. Szejtli, J.: Medicinal applications of cyclodextrins. Med. Res. Rev. 14, 353-386 (1994)
6. Baboota, S., Dhaliwal, M., Kohli, K.: Physicochemical characterization, in vitro dissolution behavior, and pharmacodynamic studies of rofecoxib-cyclodextrin inclusion compounds. AAPS Pharm. Sci. Tech. 6, E83-E90 (2005)
7. Ghorab, M.K., Adeyeye, M.C.: Elucidation of solution state complexation in wet-granulated oven-dried ibuprofen and β-cyclodextrin: FT-IR and 1H-NMR studies. Pharm. Dev. Technol., 6, 315-324 (2001)
8. Veiga, F.J., Fernandes, C., Carvalho, R.A., Geraldes, C.F.: Molecular modeling and 1H-NMR: ultimate tools for the investigation of tolbutamide: β-cyclodextrin and tolbutamide: hydroxypropyl-β-cyclodextrin complexes. Chem. Pharm. Bull. 49, 1251-1256 (2001)
9. Tirucherai, G.S., Mitra, A.K.: Effect of hydroxypropyl beta cyclodextrin complexation on aqueous solubility, stability, and corneal permeation of acyl ester prodrugs of ganciclovir. AAPS Pharm. Sci. Tech. 4, E45 (2003)
10. Nalluri, B.N., Chowdary, K.P.R., Murthy, K.V.R., Hayman, A.R., Becket, G.: Physicochemical characterization and dissolution properties of nimesulide-cyclodextrin binary systems. AAPS Pharm. Sci. Tech. 4, E2 (2003)
11. Moore, J.W., Flanner, H.: Mathematical comparison of dissolution profiles. Pharm. Tech. 20, 64-74 (1996)
12. Reppas, C., Nicolaides, E.: Analysis of drug dissolution data, In: Dressman, J.B., Lennernäs, H. (Eds.), Oral drug absorption prediction and assessment, pp. 229-254. Marcel Dekker, New York (2000)
13. Vueba, M.L., Batista de Carvalho, L.A.E., Veiga, F., Sousa, J.J., Pina, M.E.: Influence of cellulose ether polymers on ketoprofen release from hydrophilic matrix tablets. Eur. J. Pharm. Biopharm. 58, 51-59 (2004)
14. Higuchi, T., Connors, K.: Phase solubility techniques. Adv. Anal. Chem. Instru. 4, 17-123 (1965)
15. Peri, D., Wyandt, C.M., Cleary, R.W., Hickal, A.H., Jones, A.B.: Inclusion complexes of tolnaftate with β- Cyclodextrin and hydroxy-β-cyclodextrin. Drug Dev. Ind. Pharm. 20, 1401-1410 (1994)
16. Labenderia, J.J.T., Lopez, M.E., Penin, L.S., Jato, J.L.V.: Glibornuride-β-cyclodextrin inclusion complexes: Preparation, structural characterization, and in vitro dissolution behavior. J. Pharm. Biopharm., 39, 255-259 (1993)
17. Chengsheng, L., Kashappa, H.D.: Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000. Drug Dev. Ind. Pharm. 1, 1-10 (2005)
18. Hedges, A.R.: Industrial applications of cyclodextrins. Chem. Rev. 98, 2035- 2044 (1998)
19. Vromans, H., Eisson, A.C., Coenraad, F.L.: Mechanism of dissolution of drug-cyclodextrin complexes. Drug Dev. Ind. Pharm. 15, 250-255 (1989)